Biopharmaceutical
-
{
- All
- News
- Videos
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
This 24-Year-Old, Rihanna's Friend, Just Became An Overnight Billionaire
Need a fail-proof recipe for instant billionaire? Just take the 24-year-old son of pharmaceutical moguls and add $3.8 billion in shares from the family business, gratis.
-
Fire At Biocon's Research Subsidiary In Bengaluru, No Casualties Reported
A fire broke out on Monday at the premises of Syngene, the contract research subsidiary of Biocon, but there were no reports of any casualties.
-
Time For India To Be Innovator Nation In Bio-Pharma: Expert
India has a "strong potential" to become a hub for biopharmaceutical innovation and the time has come for it to emerge as an innovator nation in this sector, a top industry leader has said.
-
'Pharma Bro' Shkreli Arrested For Securities Fraud
Martin Shkreli is a biotech executive who favors open-collar shirts over lab coats, the founder of a hedge fund who eschewed discretion by broadcasting his life on YouTube, a pill seller who made no bones about his power to raise the price of his medicines.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
An Indian Pharma Is Working On Omicron-Specific Vaccine: Report
India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.
-
India's 1st Homegrown mRNA Vaccine Approved For More Clinical Trials
Pharmaceutical firm Gennova Biopharmaceuticals' COVID-19 vaccine, the first homegrown mRNA-based shot, was found to be safe and effective in an early-stage study, the government said on Tuesday.
-
Gennova Starts Enrolment For Human Trials Of HGCO19 Vaccine Candidate: Report
Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.
-
India's First Homemade mRNA Vaccine Gets Permission To Start Human Trials
An anti-Coronavirus vaccine being developed by the Pune-based company, Gennova, has become the first indigenous mRNA candidate to have received approval to initiate human clinical trial, a central government statement has said.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
China Biopharma Plant Leak Infects Thousands With Bacterial Disease
Another 1,401 people tested as an early positive for the disease, and health authorities said there was no evidence of person-to-person transmission so far.
-
This 24-Year-Old, Rihanna's Friend, Just Became An Overnight Billionaire
Need a fail-proof recipe for instant billionaire? Just take the 24-year-old son of pharmaceutical moguls and add $3.8 billion in shares from the family business, gratis.
-
Fire At Biocon's Research Subsidiary In Bengaluru, No Casualties Reported
A fire broke out on Monday at the premises of Syngene, the contract research subsidiary of Biocon, but there were no reports of any casualties.
-
Time For India To Be Innovator Nation In Bio-Pharma: Expert
India has a "strong potential" to become a hub for biopharmaceutical innovation and the time has come for it to emerge as an innovator nation in this sector, a top industry leader has said.
-
'Pharma Bro' Shkreli Arrested For Securities Fraud
Martin Shkreli is a biotech executive who favors open-collar shirts over lab coats, the founder of a hedge fund who eschewed discretion by broadcasting his life on YouTube, a pill seller who made no bones about his power to raise the price of his medicines.
